QSBS Section 1202 Tax Exclusion 2026: How Founders and Investors Skip Federal Capital Gains

Can you really pay zero federal tax on a startup exit?

For a narrow but very real set of people, the answer is yes—and Section 1202 of the tax code is how. My read after watching founders navigate this: QSBS is the most underused seven-figure tax break in the startup world, not because it is obscure, but because the qualification is a chain of technical conditions and any broken link voids the whole thing. Miss the entity type, sell a few months early, or take the wrong redemption, and a gain you thought was tax-free becomes fully taxable.

Here is the payoff in one sentence. If you hold qualified small business stock in a domestic C-corporation long enough and the company checks the right boxes, you can exclude up to 100% of the federal capital gain on sale, capped per company at the greater of a fixed dollar amount or ten times your basis. That cap floor has historically been $10 million; for stock newly issued under the 2025 law it steps higher. On a genuine startup exit, the 10x-basis prong often blows past both numbers.

This is a practical walkthrough, not tax advice. QSBS is fact-specific and the penalty for guessing is a seven-figure surprise, so treat everything below as the map you bring to a CPA or tax attorney—not a substitute for one.

Who is Section 1202 actually built for?

Three groups win here, and they win differently.

Founders get the biggest headline benefit because their basis is usually tiny—they bought founder shares for a few hundred dollars—so the exclusion caps out at the dollar floor rather than the 10x prong. A founder who sells for $12 million with almost no basis can exclude the full dollar-cap amount and, with planning, more.

Early employees who exercise options and hold the resulting stock can qualify, but timing is everything. The QSBS clock generally runs from when you acquire the actual shares, not from your grant date. Employees who exercise early—and file an 83(b) election where relevant—start the five-year clock years sooner than those who wait until an exit is in sight.

Angel and seed investors benefit from the 10x-basis prong. Because they put real money in, a $500,000 investment that returns $6 million can exclude the entire gain under the 10x rule even though it exceeds the plain dollar floor for that block of stock.

The common thread: original-issue stock in a real operating C-corporation, acquired directly from the company, held with intention. Buying shares on a secondary market from another shareholder generally does not produce QSBS in your hands.

What makes stock “qualified”? The eligibility checklist

Every condition below has to be true. This is where deals quietly fail.

Requirement	What it means	Where founders slip
Domestic C-corporation	Stock must be in a US C-corp at issuance and essentially throughout the hold	Delaying LLC-to-C-corp conversion; the clock only starts at conversion
Original issuance	Acquired directly from the company for money, property, or services	Buying secondary shares from another holder—usually not QSBS
Gross assets test	Company’s gross assets at or below the threshold immediately before and after issuance	Later growth is fine; the test is at issuance, but documentation is thin
Active business (80%)	At least 80% of assets used in a qualified active trade or business	Sitting on a large cash/investment pile can fail the active-asset test
Qualified trade	Not a disqualified service or excluded industry	Consulting/finance/health/hospitality labels can taint an otherwise good company
Holding period	Held long enough (classically five years)	Selling at 4 years 9 months—the single most painful miss
No disqualifying redemption	Company avoids certain stock buybacks around your purchase	Founder buyback of a departing co-founder can taint nearby issuances

Two of these deserve emphasis. The gross assets test looks at the moment of issuance—if the company was under the threshold when you got your stock, later ballooning to hundreds of millions does not retroactively disqualify you. That is why getting stock early matters beyond just price. And the excluded-industry list is broader than people expect: it sweeps in health, law, accounting, consulting, financial services, brokerage, banking, insurance, actuarial work, performing arts, athletics, hospitality (hotels and restaurants), farming, and mineral extraction. Most software and product companies are clear; a fintech or a telehealth company needs a careful look at whether it is a technology business or a disqualified service business wearing a tech logo.

How big is the exclusion, and how does the 2025 change it?

The cap is per taxpayer, per issuing company: the greater of a fixed dollar floor or ten times your adjusted basis. Because it resets per company, someone with stock in three qualifying startups has three separate caps.

The 2025 legislation (the reconciliation package widely tracked as OBBBA) reshaped the timeline and dials for stock newly issued after its effective date. Rather than a single five-year cliff, newer stock gets a tiered exclusion, and both the dollar cap and the gross-assets threshold were raised, with inflation indexing. Older stock keeps the pre-2025 rules. The exact indexed figures are the sort of detail worth confirming against current IRS guidance rather than memorizing, but the direction is unambiguous: the benefit got bigger and more flexible for new issuances.

Holding period	Newly issued stock (post-2025)	Stock issued before the 2025 change
Under 3 years	No exclusion	No exclusion
3 years	Partial exclusion (roughly half)	No exclusion
4 years	Larger partial exclusion (roughly three-quarters)	No exclusion
5 years or more	Full exclusion, up to the cap	Full exclusion (100% for post-Sept 2010 stock), up to the cap

For fully excluded stock acquired after late 2010, the excluded gain is also not an alternative minimum tax preference item and is excluded from the net investment income tax—so “100%” really can mean 100%. Stock qualifying only for older 50% or 75% exclusions carries an AMT wrinkle on part of the excluded gain. If your stock predates the 100% era, that detail changes the math.

Stacking and packing: multiplying one cap into many

Because the cap is per taxpayer, the highest-leverage planning move is to create more taxpayers. This is QSBS stacking.

The mechanic: before a sale, the shareholder gifts blocks of QSBS to separate non-grantor trusts (often for the benefit of children or other family) and sometimes directly to family members. A gift of QSBS carries the stock’s QSBS character and holding period to the recipient. Each properly structured non-grantor trust is its own taxpayer with its own exclusion cap. Spread $40 million of anticipated gain across several trusts, and each trust can shelter up to its own cap rather than everyone sharing one.

Two cautions make or break this. First, the trusts have to be genuine, separate, non-grantor trusts—if they are all effectively controlled by and taxed to the founder, the IRS can collapse them. Second, gifting has estate and gift tax consequences of its own; using the lifetime exemption to fund these trusts is often the point, which is exactly why QSBS and estate planning are done together. Anyone deep in QSBS stacking is usually also thinking about the exemption sunset, which is its own project—see the companion guide to choosing an estate tax planning attorney in 2026.

“Packing” is the related move on the basis side: contributing appreciated property into the company at formation to raise your basis, which lifts the 10x-basis prong of the cap. It is subtler and easier to get wrong, and it interacts with how gain is measured, so it is firmly professional-only territory.

What if the company sells before five years? Section 1045

Early acquisitions happen, and they can strand a founder at four years with a taxable gain. Section 1045 is the escape hatch. If you have held QSBS more than six months and sell, you can roll the proceeds into new QSBS within 60 days and defer the gain, carrying your original holding period into the replacement stock. In practice that means an early exit does not have to burn the clock—reinvest into another qualifying company and you keep marching toward the five-year finish line.

The rollover has strict timing and reinvestment rules, and any proceeds you do not reinvest are taxable. It is a valuable tool precisely because early M&A is common, but it rewards moving fast and documenting carefully.

The state problem: your state may tax what the IRS forgives

Federal exclusion is only half the picture. States write their own rules, and most—but not all—conform to Section 1202. The one that stings is California, which provides no QSBS exclusion at all. A California founder can exclude a gain federally and still owe full California tax on the same gain, which at the top state rate is a meaningful bite out of a “tax-free” exit. A few other states have historically been non-conforming or partial.

This drives real decisions. Some founders time a change of residency before a liquidity event; others simply budget for the state tax and are pleasantly surprised if a move is feasible. The point is not to assume federal treatment flows through to your state—confirm your specific state’s conformity, because the gap can be seven figures on its own. For the broader mechanics of how capital gains are taxed and reported, the capital gains tax guide for 2026 is a useful companion.

The mistakes that quietly blow the exclusion

Most QSBS failures are not exotic. They are ordinary process errors that only surface at exit, when nothing can be fixed.

• Selling too early. Four years and nine months is not five years. Buyers do not care about your QSBS clock; if you can influence closing timing, a few weeks can be worth a fortune.
• Wrong entity, wrong timing. Staying an LLC or S-corp too long means the clock has not started. Converting to a C-corp resets the basis and starts QSBS, but only from the conversion date.
• Bad redemptions. Certain company stock buybacks near your purchase—like buying out a departing founder—can taint the QSBS status of stock issued around the same window.
• Blowing the active-business or industry test. A company that piles up cash and investments instead of operating assets, or that drifts into a disqualified service line, can fail even if it started clean.
• No documentation. QSBS status is proven with facts: incorporation date, gross assets at issuance, cap table, business activity. Founders who never gathered a QSBS attestation from the company scramble at the worst possible moment.
• Assuming the whole gain qualifies. The cap is real. Gain above the greater-of cap is ordinary capital gain, and planning (stacking, multiple issuers) is how large exits stay mostly excluded.

Is chasing QSBS worth the effort?

For a founder or early investor with a plausible seven-figure outcome, unquestionably yes—the difference between a fully taxable exit and a fully excluded one is often the largest single number on the return. The work is front-loaded and cheap relative to the payoff: incorporate as a C-corp at the right time, acquire original-issue stock, document gross assets at issuance, keep the company inside a qualified trade, and hold. The planning layer—stacking through trusts, 1045 rollovers, residency and state conformity—is where a specialist earns their fee many times over.

What it is not is a do-it-yourself project. The rules are unforgiving, several are irreversible, and the 2025 changes added a tiered timeline that rewards knowing exactly which vintage of stock you hold. If a meaningful exit is anywhere on your horizon, the move is to get a QSBS analysis on paper early—not the week the term sheet arrives. For founders also weighing equity strategy more broadly, the 2026 capital gains guide and a read on where growth capital is flowing in the AI stocks investment guide round out the picture.

---

This article is for general informational purposes only and is not legal, tax, or investment advice. Section 1202 qualification is highly fact-specific, and federal and state rules change. Consult a licensed CPA or tax attorney about your own situation before making any decision or relying on QSBS treatment.